24/7 Wall St.1d agoneutral
Gilead Pays a $3.28 Annual Dividend Despite Negative Earnings. Is It Safe?Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
107last 24h
3126last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.3d agobullish
Did Earnings Beat Just Shift Gilead Sciences' (GILD) Investment Narrative?Investor's Business Daily9d agoneutral
How Gilead, Which Just Hit A Record, Notched Its Best Sales Growth In A DecadeMT Newswires9d agobullish
UBS Adjusts Gilead Sciences Price Target to $195 From $175, Maintains Buy RatingSimply Wall St.41d agoneutral
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend?Pharmaceutical Technology60d agoneutral
Gilead launches research facility in US for new medicine developmentInsider Monkey77d agoneutral
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?